Denny Lanfear

Track

Insider profile

Currently holds a position at Coherus Oncology Inc

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 38% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer Coherus Oncology Inc Feb. 1, 2016 -
Chairman of the Board, President, Chief Executive Officer Coherus Oncology Inc Sept. 1, 2010 - Feb. 1, 2016
Denny Lanfear's trades of Coherus Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
334.90
Quantity 91,354 -31.5%
Value US$3,795,960
Transaction date
Proposed sale
Price
213.90
Quantity 84,817
Value US$3,075,043
Transaction date
Planned sale
Price
31.79
Quantity 2,900 -0.2%
Value US$92,199
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-24 2023-11-22
S Sale
91,354 -31.5%
334.90
US$3,795,960 		91,354 -31.5% 334.90 US$3,795,960
2023-11-22 2023-11-22
PrS Proposed sale
84,817
213.90
US$3,075,043 		84,817 213.90 US$3,075,043
2021-06-08 2021-06-08
S Sale
35,283 -11.6%
272.66
US$3,599,157 		35,283 -11.6% 272.66 US$3,599,157
2019-11-25 2019-11-21
S Sale
12,500 -2.7%
18.56
US$231,960 		12,500 -2.7% 18.56 US$231,960
2019-05-31 2019-05-30
S Sale
32,398 -2.5%
19.49
US$631,282 		32,398 -2.5% 19.49 US$631,282
2016-09-22 2016-09-21
PlS Planned sale
50 -0.0%
31.75
US$1,588 		50 -0.0% 31.75 US$1,588
2016-09-20 2016-09-16
PlS Planned sale
2,900 -0.2%
31.79
US$92,199 		2,900 -0.2% 31.79 US$92,199